Navigation Links
Viertel Foundation Fellowship for leading cancer researcher
Date:11/8/2010

Walter and Eliza Hall Institute researcher Dr Ross Dickins has been awarded a Sylvia and Charles Viertel Charitable Foundation Fellowship worth $AUD975,000 over five years.

Dr Dickins, a laboratory head in the institute's Molecular Medicine division, is investigating the genes involved in cancer development, particularly leukaemia, using short hairpin RNA (shRNA) techniques he developed that help identify the function of genes by switching the genes on and off.

"The techniques harness a natural process of gene silencing known as RNA interference and allow us to quickly and effectively study multiple cancer genes in new ways," Dr Dickins said.

The Viertel Fellowship will allow Dr Dickins to continue his work towards identifying the normal function of genes recently implicated in leukaemia.

Dr Dickins said it was an honour to be named the 2010 Viertel Fellow.

"Charles Viertel was a hugely generous Australian philanthropist, yet during his lifetime he sought little public recognition," Dr Dickins said.

"It is a great privilege to receive a fellowship from the charitable foundation he established." Dr Dickins explained that the research supported by the fellowship aimed to better understand the genetic changes that bring about leukaemia. With that knowledge new therapeutic targets for cancer could be identified, he said.

"We are examining several genes that are known to be altered in human leukaemia, along with a new set of genes that are thought to be involved but whose functions in normal blood cells and leukaemia cells remain untested," Dr Dickins said.

"Ultimately, we hope that shRNA technology will accelerate cancer drug discovery by identifying genes that could be targeted by new therapeutic agents, in particular for leukaemias and lymphomas," he said.

"In an ideal future, the research will help match the genetic profile of a tumour with the best possible therapeutic agent to treat that particular tumour."

The Sylvia and Charles Viertel Charitable Foundation is one of the largest charitable foundations in Australia, awarding almost $9 million through its grant programs each year.


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. Landenberger Foundation awards grant to Scripps Florida scientist to study HIV
2. Entomological Foundation names 2010 award winners
3. American Migraine Foundation launches new podcast series
4. UofL researcher receives grant from the National Science Foundation
5. Stem cell, artificial liver research receives Coulter Foundation funding at NJIT
6. The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011
7. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
8. 12 women scientists announced as winners of Elsevier Foundation TWOWS Awards
9. NYSCF receives $27 million grant from Robertson Foundation to promote stem cell research
10. International Osteoporosis Foundation honors longtime associate
11. More Than 100 Global and U.S. Municipal Leaders Join Mayor Daley, Business, Civic, Academic and Foundation Leaders at 2010 Richard J. Daley Global Cities Forum
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Viertel Foundation Fellowship for leading cancer researcher
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
Breaking Biology News(10 mins):
(Date:4/25/2017)... , April 25, 2017 ... ("EpiVax") has licensed its novel immune-modulating technology to an ... disease and allergy. Tregitopes, pronounced T·rej·itopes, ... human immunoglobulin by EpiVax CEO Annie De ... to intravenous immunoglobulin G, an autoimmune disease therapy, ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Partners.     , Covalent’s Analytical Services unit provides high-quality data to clients, ... within 24 hours of receipt. There are no price premiums, and customers are ...
(Date:4/24/2017)... ... April 24, 2017 , ... It ... a cellular milieu; however, the broad application of this cellular target engagement concept ... sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods for particular applications, ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... manufactures in 10 categories with over 30 nominees and well as the first-year ... the new award and the event was hosted by CompanyWeek and Manufacturers Edge, ...
Breaking Biology Technology: